Welcome to The CAPS Community!

This revolutionary service pools the resources of the Motley Fool Community to help you identify the best stocks at the best times to buy them -- and which stocks to avoid. Learn More or watch a quick intro video from David Gardner.

Be a smarter investor in just 3 steps...

  • Rate Stocks

    Test your picks against the best investors. Rate a stock!

  • Research Stocks

    Tap into community intelligence to find the best stocks. Find stock ideas!

  • Share Your Ideas

    Exchange thoughts with other active investors. Start blogging!

Recent Stock Pitches

  • Outperform
    Harbinger Group (HRG)

    39 minutes ago by OklaBoston (67.66) | Reply

    Valuations and positive ease worries about the debt load. Up-trend from less than $5 should last a while longer.

  • Outperform
    Dara Biosciences Inc (DARA)

    1 hour ago by Deepvaluestocks (< 20) | Reply

    There are numerous potential catalysts upcoming that can close this valuation gap, with a potential partnership for KRN5500 being the most likely upside scenario.

  • Outperform
    Minerva Neurosciences (NERV)

    1 hour ago by Deepvaluestocks (< 20) | Reply

    Given the impressive players involved, the numerous catalysts over the next two quarters, and unlikelihood of dilution in the next six months, I am initiating Minerva Neurosciences with a buy.

  • Outperform
    Oxigene Inc (OXGN)

    1 hour ago by Deepvaluestocks (< 20) | Reply

    Considering the strong balance sheet, I believe that the current EV of about $5 million undervalues fosbretabulin's potential, leading me to place a buy recommendation on the stock.

  • Outperform
    OncoGenex Pharmaceuticals (OGXI)

    1 hour ago by Deepvaluestocks (< 20) | Reply

    Given the numerous catalysts and apatorsen's effectiveness in the lower-performance subgroup in Borealis-1, I believe that the current depressed valuation and minimal enterprise value present an attractive entry point.

  • Outperform
    AstraZeneca plc (ADR) (AZN)

    2 hours ago by pest1948 (< 20) | Reply

    appl

  • Outperform
    Endocyte, Inc. (ECYT)

    2 hours ago by BGRaven (< 20) | Reply

    pipeline drugs

  • Outperform
    Virnetx Holding Corp. (VHC)

    6 hours ago by OklaBoston (67.66) | Reply

    A feature of http://www.seekingalpha.com I hadn't noticed before says this has positive FCF, and that seems to be rarer than I expected before discovering the above-mentioned feature.

    It also has ... More

  • Outperform
    Paychex, Inc. (PAYX)

    6 hours ago by CmpsVktr (< 20) | Reply

    I expect PAYX to outperform the S&P 500 on a total return basis over the next 5 years. From a capital appreciation standpoint, PAYX and the market appear to be even. Both have a P/FV ratio that is between 1.00 to 1.02 at current levels. Howev... More

  • Outperform
    Kinder Morgan, Inc. (KMI)

    7 hours ago by miwsflog (< 20) | Reply

    Newly combined company shows relative strength performance in face of the past few months industry declines. Experienced management.

  • Outperform
    North Atlantic Drilling (NADL)

    8 hours ago by cowcamp (58.32) | Reply

    Event driven stock at the moment. Lifting of Russian sanctions will open the Rosneft deal to fruition. Price of $3 at $75 oil (11/19/2014)requires a lot of oil to be taken off the table to help in that arena. Not a takeover as SDRL owns over 70%. Onl... More

  • Outperform
    Kinder Morgan, Inc. (KMI)

    8 hours ago by rmh9962 (< 20) | Reply

    Unlike many companies in the energy sector, especially oil, Kinder Morgan can drive profits in low and and high oil price environments. While KMI will certainly perform better with higher oil prices, they are able to buffer the low prices with their... More

  • Outperform
    Vertex Pharmaceuticals, Inc. (VRTX)

    10 hours ago by marsuculix (31.80) | Reply

    PDUFA on Dec 30 likely to be positive for Vertex's Kalydeco...

  • Outperform
    Galectin Therapeutics Inc. (GALT)

    15 hours ago by zzlangerhans (99.85) | Reply

    I'm a long-term bear on Galectin, but a lot has changed since I registered my disgust in early 2013. The share price rose as high as 18 last February in the froth of hysteria about NASH after the "Intercept event" and some vague claims of i... More

  • Outperform
    Synergy Pharmaceuticals Inc Fl (SGYP)

    18 hours ago by spburnsse (< 20) | Reply

    Their primary drug in their drug pipeline is Plecanatide, which treats constipation and IBS. It is in stage three clinical trial and should be to market by the end of 2015.

  • Underperform
    UMB Financial Corp (UMBF)

    19 hours ago by OklaBoston (67.66) | Reply

    A high PEG and a "SELL" ranking from http://www.zacks.com are a bad combination in any market.

  • Underperform
    Directv (DTV)

    20 hours ago by OklaBoston (67.66) | Reply

    $35 is the most I would pay for this.

  • Underperform
    Colfax Corp. (CFX)

    20 hours ago by OklaBoston (67.66) | Reply

    Down-trended stock I would pay no more than $25 for.

  • Underperform
    Coach, Inc. (COH)

    23 hours ago by moontan (< 20) | Reply

    Loosing market share to Michael Kors and others

  • Underperform
    Ocata Therapeutics, Inc. (OCAT)

    December 27, 2014 by pchop12316 (75.74) | Reply

    bigger drop iminent

Top Fool

bbmaven
  • bbmaven
  • Rating: 100.00
  • Score: 34787.24

In the end, everyone agrees that it’s the long-term that matters until the short-term starts happening. Josh Brown

Market Movers

Best

Worst

Most Pitches Today

GALE $1.53 Up +0.04 (+2.68%)
Galena Biopharma, ... CAPS Rating: 1 out of 5
F $15.45 Up +0.15 (+0.98%)
Ford Motor Company CAPS Rating: 4 out of 5
AMZN $309.18 Up +6.06 (+2.03%)
Amazon.com, Inc. CAPS Rating: 3 out of 5
KMI $42.70 Up +0.69 (+1.64%)
Kinder Morgan, Inc... CAPS Rating: 5 out of 5
JD $24.56 Down -0.05 (-0.20%)
JD.com CAPS Rating: 2 out of 5

Featured Broker Partners


Advertisement